1-4 of 4
Gaël Roué
Close
Sort by
Journal Articles

The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak

Patricia Pérez-Galán, Gaël Roué, Neus Villamor, Elias Campo, Dolors Colomer
Journal: Blood
Blood (2007) 109 (10): 4441–4449.
https://doi.org/10.1182/blood-2006-07-034173
Published: 2007
Journal Articles

Selective Inhibition of I kappaB Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing c-FLIP Level.

Gaël Roué, PhD, Patricia Pérez-Galán, PhD, Mónica López-Guerra, BS, Neus Villamor, MD, PhD, Elias Campo, MD, PhD, Dolors Colomer, PhD
Journal: Blood
Blood (2006) 108 (11): 258.
https://doi.org/10.1182/blood.V108.11.258.258
Published: 2006
Journal Articles

Activity of Bendamustine (TREANDA™) in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells with Alterations in DNA Damage Response Pathway.

Gaël Roué, PhD, Mónica López-Guerra, BS, Pierre Milpied, BS, Patricia Pérez-Galán, PhD, Neus Villamor, MD,PhD, Elias Campo, MD,PhD, Dolors Colomer, PhD
Journal: Blood
Blood (2006) 108 (11): 2510.
https://doi.org/10.1182/blood.V108.11.2510.2510
Published: 2006
Journal Articles

The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

Patricia Pérez-Galán, Gaël Roué, Neus Villamor, Emili Montserrat, Elias Campo, Dolors Colomer
Journal: Blood
Blood (2006) 107 (1): 257–264.
https://doi.org/10.1182/blood-2005-05-2091
Published: 2006